世界のダルファンプリジン市場予測2023-2029：10mg、その他

【英語タイトル】Dalfampridine Market, Global Outlook and Forecast 2023-2029

・商品コード：MMG23LY8448
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：71
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のダルファンプリジン市場規模と予測を収録しています。・世界のダルファンプリジン市場：売上、2018年-2023年、2024年-2029年
・世界のダルファンプリジン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のダルファンプリジン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「10mg」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

ダルファンプリジンのグローバル主要企業は、Acorda Therapeutics、 Elan Pharma、 Biogen、 Sun Pharmaceutical、 Aurobindo Pharmaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、ダルファンプリジンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のダルファンプリジン市場：タイプ別、2018年-2023年、2024年-2029年
世界のダルファンプリジン市場：タイプ別市場シェア、2022年
・10mg、その他

世界のダルファンプリジン市場：用途別、2018年-2023年、2024年-2029年
世界のダルファンプリジン市場：用途別市場シェア、2022年
・病院、診療所、その他

世界のダルファンプリジン市場：地域・国別、2018年-2023年、2024年-2029年
世界のダルファンプリジン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるダルファンプリジンのグローバル売上、2018年-2023年
・主要企業におけるダルファンプリジンのグローバル売上シェア、2022年
・主要企業におけるダルファンプリジンのグローバル販売量、2018年-2023年
・主要企業におけるダルファンプリジンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Acorda Therapeutics、 Elan Pharma、 Biogen、 Sun Pharmaceutical、 Aurobindo Pharma

*************************************************************

・調査・分析レポートの概要
ダルファンプリジン市場の定義
市場セグメント
世界のダルファンプリジン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のダルファンプリジン市場規模
世界のダルファンプリジン市場規模：2022年 VS 2029年
世界のダルファンプリジン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのダルファンプリジンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のダルファンプリジン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：10mg、その他
ダルファンプリジンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
ダルファンプリジンの用途別グローバル売上・予測

・地域別市場分析
地域別ダルファンプリジン市場規模 2022年と2029年
地域別ダルファンプリジン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Acorda Therapeutics、 Elan Pharma、 Biogen、 Sun Pharmaceutical、 Aurobindo Pharma
...

Dalfampridine is a potassium channel blocker used to help multiple sclerosis patients walk. This is the first drug that was specifically approved to help with mobility in these patients.
This report aims to provide a comprehensive presentation of the global market for Dalfampridine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dalfampridine. This report contains market size and forecasts of Dalfampridine in global, including the following market information:
Global Dalfampridine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Dalfampridine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Dalfampridine companies in 2022 (%)
The global Dalfampridine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
10 mg Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Dalfampridine include Acorda Therapeutics, Elan Pharma, Biogen, Sun Pharmaceutical and Aurobindo Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dalfampridine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dalfampridine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Dalfampridine Market Segment Percentages, by Type, 2022 (%)
10 mg
Others
Global Dalfampridine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Dalfampridine Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Dalfampridine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Dalfampridine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dalfampridine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Dalfampridine revenues share in global market, 2022 (%)
Key companies Dalfampridine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Dalfampridine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Acorda Therapeutics
Elan Pharma
Biogen
Sun Pharmaceutical
Aurobindo Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Dalfampridine, market overview.
Chapter 2: Global Dalfampridine market size in revenue and volume.
Chapter 3: Detailed analysis of Dalfampridine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Dalfampridine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Dalfampridine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Dalfampridine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Dalfampridine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Dalfampridine Overall Market Size
2.1 Global Dalfampridine Market Size: 2022 VS 2029
2.2 Global Dalfampridine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Dalfampridine Sales: 2018-2029
3 Company Landscape
3.1 Top Dalfampridine Players in Global Market
3.2 Top Global Dalfampridine Companies Ranked by Revenue
3.3 Global Dalfampridine Revenue by Companies
3.4 Global Dalfampridine Sales by Companies
3.5 Global Dalfampridine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Dalfampridine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Dalfampridine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Dalfampridine Players in Global Market
3.8.1 List of Global Tier 1 Dalfampridine Companies
3.8.2 List of Global Tier 2 and Tier 3 Dalfampridine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Dalfampridine Market Size Markets, 2022 & 2029
4.1.2 10 mg
4.1.3 Others
4.2 By Type – Global Dalfampridine Revenue & Forecasts
4.2.1 By Type – Global Dalfampridine Revenue, 2018-2023
4.2.2 By Type – Global Dalfampridine Revenue, 2024-2029
4.2.3 By Type – Global Dalfampridine Revenue Market Share, 2018-2029
4.3 By Type – Global Dalfampridine Sales & Forecasts
4.3.1 By Type – Global Dalfampridine Sales, 2018-2023
4.3.2 By Type – Global Dalfampridine Sales, 2024-2029
4.3.3 By Type – Global Dalfampridine Sales Market Share, 2018-2029
4.4 By Type – Global Dalfampridine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Dalfampridine Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application – Global Dalfampridine Revenue & Forecasts
5.2.1 By Application – Global Dalfampridine Revenue, 2018-2023
5.2.2 By Application – Global Dalfampridine Revenue, 2024-2029
5.2.3 By Application – Global Dalfampridine Revenue Market Share, 2018-2029
5.3 By Application – Global Dalfampridine Sales & Forecasts
5.3.1 By Application – Global Dalfampridine Sales, 2018-2023
5.3.2 By Application – Global Dalfampridine Sales, 2024-2029
5.3.3 By Application – Global Dalfampridine Sales Market Share, 2018-2029
5.4 By Application – Global Dalfampridine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Dalfampridine Market Size, 2022 & 2029
6.2 By Region – Global Dalfampridine Revenue & Forecasts
6.2.1 By Region – Global Dalfampridine Revenue, 2018-2023
6.2.2 By Region – Global Dalfampridine Revenue, 2024-2029
6.2.3 By Region – Global Dalfampridine Revenue Market Share, 2018-2029
6.3 By Region – Global Dalfampridine Sales & Forecasts
6.3.1 By Region – Global Dalfampridine Sales, 2018-2023
6.3.2 By Region – Global Dalfampridine Sales, 2024-2029
6.3.3 By Region – Global Dalfampridine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Dalfampridine Revenue, 2018-2029
6.4.2 By Country – North America Dalfampridine Sales, 2018-2029
6.4.3 US Dalfampridine Market Size, 2018-2029
6.4.4 Canada Dalfampridine Market Size, 2018-2029
6.4.5 Mexico Dalfampridine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Dalfampridine Revenue, 2018-2029
6.5.2 By Country – Europe Dalfampridine Sales, 2018-2029
6.5.3 Germany Dalfampridine Market Size, 2018-2029
6.5.4 France Dalfampridine Market Size, 2018-2029
6.5.5 U.K. Dalfampridine Market Size, 2018-2029
6.5.6 Italy Dalfampridine Market Size, 2018-2029
6.5.7 Russia Dalfampridine Market Size, 2018-2029
6.5.8 Nordic Countries Dalfampridine Market Size, 2018-2029
6.5.9 Benelux Dalfampridine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Dalfampridine Revenue, 2018-2029
6.6.2 By Region – Asia Dalfampridine Sales, 2018-2029
6.6.3 China Dalfampridine Market Size, 2018-2029
6.6.4 Japan Dalfampridine Market Size, 2018-2029
6.6.5 South Korea Dalfampridine Market Size, 2018-2029
6.6.6 Southeast Asia Dalfampridine Market Size, 2018-2029
6.6.7 India Dalfampridine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Dalfampridine Revenue, 2018-2029
6.7.2 By Country – South America Dalfampridine Sales, 2018-2029
6.7.3 Brazil Dalfampridine Market Size, 2018-2029
6.7.4 Argentina Dalfampridine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Dalfampridine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Dalfampridine Sales, 2018-2029
6.8.3 Turkey Dalfampridine Market Size, 2018-2029
6.8.4 Israel Dalfampridine Market Size, 2018-2029
6.8.5 Saudi Arabia Dalfampridine Market Size, 2018-2029
6.8.6 UAE Dalfampridine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Acorda Therapeutics
7.1.1 Acorda Therapeutics Company Summary
7.1.2 Acorda Therapeutics Business Overview
7.1.3 Acorda Therapeutics Dalfampridine Major Product Offerings
7.1.4 Acorda Therapeutics Dalfampridine Sales and Revenue in Global (2018-2023)
7.1.5 Acorda Therapeutics Key News & Latest Developments
7.2 Elan Pharma
7.2.1 Elan Pharma Company Summary
7.2.2 Elan Pharma Business Overview
7.2.3 Elan Pharma Dalfampridine Major Product Offerings
7.2.4 Elan Pharma Dalfampridine Sales and Revenue in Global (2018-2023)
7.2.5 Elan Pharma Key News & Latest Developments
7.3 Biogen
7.3.1 Biogen Company Summary
7.3.2 Biogen Business Overview
7.3.3 Biogen Dalfampridine Major Product Offerings
7.3.4 Biogen Dalfampridine Sales and Revenue in Global (2018-2023)
7.3.5 Biogen Key News & Latest Developments
7.4 Sun Pharmaceutical
7.4.1 Sun Pharmaceutical Company Summary
7.4.2 Sun Pharmaceutical Business Overview
7.4.3 Sun Pharmaceutical Dalfampridine Major Product Offerings
7.4.4 Sun Pharmaceutical Dalfampridine Sales and Revenue in Global (2018-2023)
7.4.5 Sun Pharmaceutical Key News & Latest Developments
7.5 Aurobindo Pharma
7.5.1 Aurobindo Pharma Company Summary
7.5.2 Aurobindo Pharma Business Overview
7.5.3 Aurobindo Pharma Dalfampridine Major Product Offerings
7.5.4 Aurobindo Pharma Dalfampridine Sales and Revenue in Global (2018-2023)
7.5.5 Aurobindo Pharma Key News & Latest Developments
8 Global Dalfampridine Production Capacity, Analysis
8.1 Global Dalfampridine Production Capacity, 2018-2029
8.2 Dalfampridine Production Capacity of Key Manufacturers in Global Market
8.3 Global Dalfampridine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Dalfampridine Supply Chain Analysis
10.1 Dalfampridine Industry Value Chain
10.2 Dalfampridine Upstream Market
10.3 Dalfampridine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Dalfampridine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Dalfampridine in Global Market
Table 2. Top Dalfampridine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Dalfampridine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Dalfampridine Revenue Share by Companies, 2018-2023
Table 5. Global Dalfampridine Sales by Companies, (K Units), 2018-2023
Table 6. Global Dalfampridine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Dalfampridine Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Dalfampridine Product Type
Table 9. List of Global Tier 1 Dalfampridine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dalfampridine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Dalfampridine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Dalfampridine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Dalfampridine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Dalfampridine Sales (K Units), 2018-2023
Table 15. By Type - Global Dalfampridine Sales (K Units), 2024-2029
Table 16. By Application – Global Dalfampridine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Dalfampridine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Dalfampridine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Dalfampridine Sales (K Units), 2018-2023
Table 20. By Application - Global Dalfampridine Sales (K Units), 2024-2029
Table 21. By Region – Global Dalfampridine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Dalfampridine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Dalfampridine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Dalfampridine Sales (K Units), 2018-2023
Table 25. By Region - Global Dalfampridine Sales (K Units), 2024-2029
Table 26. By Country - North America Dalfampridine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Dalfampridine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Dalfampridine Sales, (K Units), 2018-2023
Table 29. By Country - North America Dalfampridine Sales, (K Units), 2024-2029
Table 30. By Country - Europe Dalfampridine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Dalfampridine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Dalfampridine Sales, (K Units), 2018-2023
Table 33. By Country - Europe Dalfampridine Sales, (K Units), 2024-2029
Table 34. By Region - Asia Dalfampridine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Dalfampridine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Dalfampridine Sales, (K Units), 2018-2023
Table 37. By Region - Asia Dalfampridine Sales, (K Units), 2024-2029
Table 38. By Country - South America Dalfampridine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Dalfampridine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Dalfampridine Sales, (K Units), 2018-2023
Table 41. By Country - South America Dalfampridine Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Dalfampridine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Dalfampridine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Dalfampridine Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Dalfampridine Sales, (K Units), 2024-2029
Table 46. Acorda Therapeutics Company Summary
Table 47. Acorda Therapeutics Dalfampridine Product Offerings
Table 48. Acorda Therapeutics Dalfampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Acorda Therapeutics Key News & Latest Developments
Table 50. Elan Pharma Company Summary
Table 51. Elan Pharma Dalfampridine Product Offerings
Table 52. Elan Pharma Dalfampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Elan Pharma Key News & Latest Developments
Table 54. Biogen Company Summary
Table 55. Biogen Dalfampridine Product Offerings
Table 56. Biogen Dalfampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Biogen Key News & Latest Developments
Table 58. Sun Pharmaceutical Company Summary
Table 59. Sun Pharmaceutical Dalfampridine Product Offerings
Table 60. Sun Pharmaceutical Dalfampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Sun Pharmaceutical Key News & Latest Developments
Table 62. Aurobindo Pharma Company Summary
Table 63. Aurobindo Pharma Dalfampridine Product Offerings
Table 64. Aurobindo Pharma Dalfampridine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Aurobindo Pharma Key News & Latest Developments
Table 66. Dalfampridine Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 67. Global Dalfampridine Capacity Market Share of Key Manufacturers, 2021-2023
Table 68. Global Dalfampridine Production by Region, 2018-2023 (K Units)
Table 69. Global Dalfampridine Production by Region, 2024-2029 (K Units)
Table 70. Dalfampridine Market Opportunities & Trends in Global Market
Table 71. Dalfampridine Market Drivers in Global Market
Table 72. Dalfampridine Market Restraints in Global Market
Table 73. Dalfampridine Raw Materials
Table 74. Dalfampridine Raw Materials Suppliers in Global Market
Table 75. Typical Dalfampridine Downstream
Table 76. Dalfampridine Downstream Clients in Global Market
Table 77. Dalfampridine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Dalfampridine Segment by Type in 2022
Figure 2. Dalfampridine Segment by Application in 2022
Figure 3. Global Dalfampridine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Dalfampridine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Dalfampridine Revenue, 2018-2029 (US$, Mn)
Figure 7. Dalfampridine Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Dalfampridine Revenue in 2022
Figure 9. By Type - Global Dalfampridine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Dalfampridine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Dalfampridine Sales Market Share, 2018-2029
Figure 12. By Type - Global Dalfampridine Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Dalfampridine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Dalfampridine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Dalfampridine Sales Market Share, 2018-2029
Figure 16. By Application - Global Dalfampridine Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Dalfampridine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Dalfampridine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Dalfampridine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Dalfampridine Sales Market Share, 2018-2029
Figure 21. By Country - North America Dalfampridine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Dalfampridine Sales Market Share, 2018-2029
Figure 23. US Dalfampridine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Dalfampridine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Dalfampridine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Dalfampridine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Dalfampridine Sales Market Share, 2018-2029
Figure 28. Germany Dalfampridine Revenue, (US$, Mn), 2018-2029
Figure 29. France Dalfampridine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Dalfampridine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Dalfampridine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Dalfampridine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Dalfampridine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Dalfampridine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Dalfampridine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Dalfampridine Sales Market Share, 2018-2029
Figure 37. China Dalfampridine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Dalfampridine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Dalfampridine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Dalfampridine Revenue, (US$, Mn), 2018-2029
Figure 41. India Dalfampridine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Dalfampridine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Dalfampridine Sales Market Share, 2018-2029
Figure 44. Brazil Dalfampridine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Dalfampridine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Dalfampridine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Dalfampridine Sales Market Share, 2018-2029
Figure 48. Turkey Dalfampridine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Dalfampridine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Dalfampridine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Dalfampridine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Dalfampridine Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Dalfampridine by Region, 2022 VS 2029
Figure 54. Dalfampridine Industry Value Chain
Figure 55. Marketing Channels

★調査レポート[世界のダルファンプリジン市場予測2023-2029：10mg、その他] (コード：MMG23LY8448)販売に関する免責事項を必ずご確認ください。

★調査レポート[世界のダルファンプリジン市場予測2023-2029：10mg、その他]についてメールでお問い合わせ

MarketReport.jp

世界のダルファンプリジン市場予測2023-2029：10mg、その他

市場調査レポート・産業資料総合販売サイト www.MarketReport.jp

市場調査レポート・産業資料 総合販売サイト www.MarketReport.jp

市場調査レポート・産業資料総合販売サイト www.MarketReport.jp